Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

Abroad (travel likely)RecruitingPHASE2

Conditions

Colorectal Cancer Metastatic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

USC/Norris Cancer Center, Los Angeles, California, United States
Contact: Study coordinator (Rabia Rehman, MBBS, MHA) · info@med.usc.ed
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases

Colorectal Cancer Metastatic · Liver Metastases · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

New York, United States

Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases

Colorectal Cancer · KRAS G12C Mutant Advanced Solid Tumors · Fulzerasib

Abroad (travel likely)RecruitingPHASE2

Hangzhou, China

TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer

Colorectal Cancer Metastatic · Advanced Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Cancer · Breast Cancer · Non-Small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China